Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Sell
37
ZVRA Quote, Financials, Valuation and Earnings
Last price:
$8.00
Seasonality move
:
-11.97%
Day range:
$7.87 - $8.14
52-week range:
$4.20 - $9.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.69x
P/B ratio:
10.93x
Volume:
1.7M
Avg. volume:
459.9K
1-year change:
37.16%
Market cap:
$433.5M
Revenue:
$23.6M
EPS (TTM):
-$2.26
ZVRA Analysts' Consensus Rating
The 4 analysts providing 12-month price projections for Zevra Therapeutics shares anticipate an average target of $21.63, ranging from a low estimate of $17.00 to a high estimate of $25.00. This average target implies a growth of 169.98% compared to the current stock price of $8.01.
Consensus Price Target
$21.63
Highest Price Target
$25.00
Lowest Price Target
$17.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ZVRA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 20
Regencell Bioscience Holdings [RGC] is down 0% over the past day.
Sell
36
VMI alert for Mar 20
Valmont Industries [VMI] is down 0% over the past day.
Buy
61
ALNY alert for Mar 20
Alnylam Pharmaceuticals [ALNY] is down 0% over the past day.
